Jul 8, 2026 – 1.32pmResmed has sold an underperforming software business focused on residential aged care to a US private equity firm for $707 million, about a third less than what it paid for the asset eight years ago, in a move analysts say reflects the risk that artificial intelligence renders it obsolete.Resmed said the sale of MatrixCare, which provides software used to manage care, nutrition and payroll in nursing, senior living and retirement facilities, to Frazier Healthcare Partners, was part of a strategy to focus on its core sleep health business.Subscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? Fetching latest articles
Resmed sells US software business on the cheap as AI threat looms
The medical device maker has sold the MatrixCare business for less than it bought it for eight years ago, with analysts pointing to potential AI disruption.
113 words~1 min read
